Jos Prickaerts

Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment

Marc L. Molendijk, Boudewijn A.A. Bus, Ph. Spinhoven et al. · Molecular Psychiatry · 2010 · 438 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Transgenic Mice Overexpressing Glycogen Synthase Kinase 3β: A Putative Model of Hyperactivity and Mania

Jos Prickaerts, Dieder Moechars, Kim Cryns et al. · Journal of Neuroscience · 2006 · 345 citations · Full text

Medicine, Neurobiology, Neuroscience +13

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

Frank Boess, Martin Hendrix, F. Josef van der Staay et al. · Neuropharmacology · 2004 · 325 citations

Life Sciences, Neurobiology, Neuroscience +15

Determinants of serum brain-derived neurotrophic factor

Boudewijn A.A. Bus, Marc L. Molendijk, Brenda J. W. H. Penninx et al. · Psychoneuroendocrinology · 2010 · 278 citations

Medicine, Neurobiology, Neuroscience +9

Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic GMP levels in the rat

Jos Prickaerts, Wilma C.G. van Staveren, M. Markerink–van Ittersum et al. · Neuroscience · 2002 · 229 citations

Life Sciences, Neuroscience, Pharmacology +16